O'Shaughnessy Details Strategies to Strengthen ER Blockade in MBC

Gina Battaglia, PhD
Published: Tuesday, Aug 11, 2015
Joyce A. O’Shaughnessy, MD

Joyce A. O’Shaughnessy, MD

Combining estrogen receptor (ER) blockade with targeted cell-cycle inhibitors increases therapeutic options for postmenopausal women with ER-positive, HER2-negative metastatic breast cancer, contributing to an evolving paradigm that is moving new regimens to the forefront of the treatment timeline, according to Joyce A. O’Shaughnessy, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication